Atlas Trials

Ancillary Effects of Oral Naloxegol (Movantik)

Clinical trial NCT03235739 · COMPLETED

Trial details

NCT number
NCT03235739
Sponsor
The Cleveland Clinic
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Pain, Postoperative
Start date
2017-10-01
Primary completion
2021-05-31
Enrollment
136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.